Opfikon, Switzerland | September 29 – October 01, 2026 — Pharmabotix is participating as an official sponsor and exhibitor at the Robotic & AI and RAYA Award 2026 (Powered by GAMP AI), hosted at the Takeda facility in Opfikon.
Throughout the three-day event, we will be showcasing live demonstrations of our modular robotic assembly solution for small-batch autoinjectors, engineered specifically to bridge the gap between clinical trials and flexible commercial assembly.
In addition to our exhibition booth, Pharmabotix has entered the competition for the prestigious RAYA 2026 Award with two breakthrough automation systems engineered alongside our industry partners.
ISPE RAYA 2026 Award Nominees
1. High-Volume CGM Component Packaging Line (with OECHSLER HEALTH)
Developed for OECHSLER Health’s commercial production site in Ansbach, Germany, this robotic cell sets a benchmark in high-volume medical device manufacturing for Continuous Glucose Monitoring (CGM) sensor components.
- Core Metrics: Directly linked to high-cavity injection molding, delivering 1,600 parts per hour at an 18-second cycle time.
- Traceability & Integrity: Absolute cavity-pure traceability combined with automated line clearance for 24/7 continuous operation under medical standards.
- Engineering Architecture: Energy-efficient drive technology, modular hardware structure, and a software framework built for rapid recipe adjustments.
- Status: Fully qualified, CE-certified, and operating in live commercial production.
2. “Sally” – Automated Inoculum Preparation for Cell & Gene Therapy (with Stäubli Robotics)
Addressing the critical bottleneck of manual handling in advanced therapeutics, “Sally” automates the complex upstream inoculum preparation workflow under close-to-GMP conditions.
- Kinematics & Integration: Powered by a high-precision Stäubli TX2-60L 6-axis robot, orchestrating seamless sample transfers between third-party centrifuges, incubators, and liquid handling units.
- Process Reliability: Eliminates operator variability and sharply reduces contamination risks during sensitive cell culture processing.
- Architecture: Plug-and-produce system layout designed for scalable, reproducible batch execution in Grade A/B environments.
- Status: Active reference cell proving stability and validation feasibility for CGT manufacturing.
Connect With Our Engineering Team on Site
Experience our robotic autoinjector assembly cell live and discuss specific process requirements directly with our automation specialists.
- Location: Takeda, Opfikon (Zurich), Switzerland
- Dates: September 29 – October 01, 2026
- Get in Touch: solutions@pharmabotix.ch | www.pharmabotix.ch
